C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 33 | 46↑37.9% | 31↓32.1% | 21↓33.3% | 36↑71.4% |
| Gross Profit | -45 | 46↑201.2% | 31↓32.1% | 13↓58.1% | 36↑173.3% |
| Operating Income | -60 | -82↓35.9% | -130↓57.7% | -139↓7.3% | -120↑14.0% |
| Net Income | -66 | -84↓26.5% | -128↓52.8% | -132↓3.4% | -105↑20.5% |
| EBITDA | -59 | -80↓36.4% | -124↓54.9% | -122↑1.8% | -103↑15.3% |
| EPS Diluted | -1.54 | -1.82↓18.2% | -2.62↓44.0% | -2.67↓1.9% | -1.52↑43.1% |